Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Ann Tran

Physician Assistant Tampa, FL Physician Assistant

NPI 1407855430 CMS profile 10667894

5210 Webb Rd, Tampa, FL 33615

Open in the dashboard

General payments

$4,527

162 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ann Tran of Tampa, FL is reported in the CMS Open Payments database as having received $4,527 across 162 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $773 19
2024 General $1,633 61
2023 General $1,085 45
2022 General $629 24
2021 General $407 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ann Tran
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Ann Tran were reported at $773. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Ann Tran Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $407 $132 $37–$438 $132
2022 $629 $155 $48–$522 $149
2023 $1,085 $167 $52–$557 $160
2024 $1,633 $178 $55–$600 $164
2025 $773 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,581 50 payments
  2. Lilly USA, LLC $415 5 payments
  3. Janssen Biotech, Inc. $409 26 payments
  4. Galderma Laboratories, L.P. $364 14 payments
  5. Genzyme Corporation $292 12 payments
  6. Regeneron Healthcare Solutions, Inc. $204 8 payments
  7. Allergan Inc. $203 4 payments
  8. Revance Therapeutics, Inc. $154 3 payments
  9. Sun Pharmaceutical Industries Inc. $122 6 payments
  10. Mayne Pharma Inc. $114 4 payments
  11. Other $669 30 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,527 162 payments
Products named General payments · program years 2021–2025
  1. BOTOX $897 10 payments
  2. DUPIXENT Immunology $491 20 payments
  3. RINVOQ $463 23 payments
  4. TREMFYA $389 25 payments
  5. OLUMIANT $265 3 payments
  6. SKYRIZI $224 15 payments
  7. DAXXIFY $154 3 payments
  8. TALTZ $149 2 payments
  9. DUPIXENT Inflammation And Immunology $141 5 payments
  10. SPEVIGO $106 4 payments
  11. Other $1,312 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

162 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record